ONCOLOGY INSTITUTE INC/THE (TOI) Stock Earnings & Estimates
USA - NASDAQ:TOI - US68236X1000 - Common Stock
3.6 USD
+0.12 (+3.45%)
3.61 USD
+0.01 (+0.28%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 252.5M 24.38% | 324.239M 28.41% | 393.412M 21.33% | 478.81M 21.71% | 577.37M 20.58% | |
| EBITDA YoY % growth | -67.59M -58.81% | -54.278M 19.70% | -53.831M 0.82% | -12.322M 77.11% | N/A | |
| EBIT YoY % growth | -72M -56.86% | -60.151M 16.46% | -60.118M 0.05% | -35.077M 41.65% | -17.299M 50.68% | |
| Operating Margin | -28.51% | -18.55% | -15.28% | -7.33% | -3.00% | |
| EPS YoY % growth | N/A | -0.69 -36.63% | N/A 38.52% | -0.61 -42.86% | -0.28 53.33% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 32.67% | -0.10 -42.86% | -0.08 52.47% | -0.07 52.87% |
| Revenue Q2Q % growth | 123.86M 23.98% | 128.51M 28.17% | 131.35M 25.80% | 143.12M 19.46% |
| EBITDA Q2Q % growth | -3M 67.65% | 202K 103.58% | -313.1K 96.15% | -1.131M 85.16% |
| EBIT Q2Q % growth | -8.887M 35.85% | -6.34M 46.85% | -4.852M 51.05% | -5.264M 53.05% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.15 11.76% | -0.13 | -0.02 | -14.24% |
| Q1 2025 Q2Q % growth | -0.17 22.73% | % | ||
| Q4 2024 Q2Q % growth | 66.33% | -0.07 | % | |
| Q3 2024 Q2Q % growth | -0.18 5.26% | -0.06 | -0.12 | -197.03% |
| Q2 2024 Q2Q % growth | -0.17 10.53% | -0.10 | -0.07 | -68.32% |
| Q1 2024 Q2Q % growth | -0.22 -120.00% | -0.12 | -0.10 | -81.52% |
| Q4 2023 Q2Q % growth | -0.21 16.00% | -0.11 | -0.10 | -89.02% |
| Q3 2023 Q2Q % growth | -0.19 24.00% | -0.13 | -0.06 | -44.71% |
| Q2 2023 Q2Q % growth | -0.19 | -0.17 | -0.02 | -10.66% |
| Q4 2022 Q2Q % growth | -0.25 | -0.18 | -0.07 | -37.51% |
| Q3 2022 Q2Q % growth | -0.25 | -0.18 | -0.07 | -37.51% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 119.802M 21.53% | 115.75M | 4.052M | 3.50% |
| Q1 2025 Q2Q % growth | 104.41M 10.29% | % | ||
| Q4 2024 Q2Q % growth | 100.267M 16.88% | 110.24M | -9.973M | -9.05% |
| Q3 2024 Q2Q % growth | 99.9M 21.78% | 108.62M | -8.72M | -8.03% |
| Q2 2024 Q2Q % growth | 98.578M 22.88% | 104.34M | -5.762M | -5.52% |
| Q1 2024 Q2Q % growth | 94.666M 24.25% | 96.117M | -1.451M | -1.51% |
| Q4 2023 Q2Q % growth | 85.788M 20.12% | 82.862M | 2.926M | 3.53% |
| Q3 2023 Q2Q % growth | 82.035M 26.25% | 75.411M | 6.624M | 8.78% |
| Q2 2023 Q2Q % growth | 80.224M 31.69% | 74.527M | 5.697M | 7.64% |
| Q1 2023 Q2Q % growth | 76.19M 38.13% | % | ||
| Q4 2022 Q2Q % growth | 71.42M 36.56% | 65.398M | 6.022M | 9.21% |
| Q3 2022 Q2Q % growth | 64.98M 24.32% | 69.64M | -4.66M | -6.69% |
| Q2 2022 Q2Q % growth | 60.92M 22.23% | % | ||
| Q1 2022 Q2Q % growth | 55.16M 13.54% | % | ||
| Q4 2021 Q2Q % growth | 52.3M 6.80% | % | ||
| Q3 2021 Q2Q % growth | 52.27M 10.62% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | -275% |
| Revenue | -0.3% | N/A | -0.21% | -1.81% |